Site: Upper GI

Inclusion Criteria:

• No Rare Cancer in Controls
• No Prior History of Any Cancer
• Males Only for Gastric Cases
• Selected for Immunity Study
• Has Serum Material
• Has Pre-DX Most Distal Serum Available (Selected)

Matching Factors:

• Gender
• Race
• Age at Draw (+/- 1 year)
• Calendar Year of Draw
• Study Year of Draw
• Time of Draw (AM/PM)

Match Ratio: 1 to 1

Match Technique: Individual matching with replacement and cases as controls.

Additional Matching Comments: Match was already completed in 2015-00040

Analytes:

• Adiponectin
• Adipsin
• B-Cell Attracting Chemokine 1
• Basic Fibroblast Growth Factor
• C-Reactive Protein
• Chemokine (C-C Motif) Ligand 13
• Chemokine (C-C Motif) Ligand 19
• Chemokine (C-C Motif) Ligand 2
• Chemokine (C-C Motif) Ligand 20
• Chemokine (C-C Motif) Ligand 21
• Chemokine (C-C Motif) Ligand 22
• Chemokine (C-C Motif) Ligand 27
• Chemokine (C-C Motif) Ligand 8
• Chemokine (C-X-C Motif) Ligand 1
• Chemokine (C-X-C Motif) Ligand 10
• Chemokine (C-X-C Motif) Ligand 11
• Chemokine (C-X-C Motif) Ligand 12
• Chemokine (C-X-C Motif) Ligand 5
• Chemokine (C-X-C Motif) Ligand 6
• Chemokine (C-X-C Motif) Ligand 9
• Chemokine (C-X3-C Motif) Ligand 1
• Eotaxin
• Eotaxin-2
• Epidermal Growth Factor
• Epidermal Growth Factor Receptor
• Granulocyte-Colony Stimulating Factor
• Granulocyte-Macrophage Colony Stimulating Factor
• Interleukin 1 Receptor Antagonist
• Interleukin 1 beta
• Interleukin 10
• Interleukin 11
• Interleukin 12 p70
• Interleukin 13
• Interleukin 16
• Interleukin 17 A
• Interleukin 21
• Interleukin 23
• Interleukin 29
• Interleukin 3
• Interleukin 33
• Interleukin 4
• Interleukin 5
• Interleukin 6
• Interleukin 7
• Interleukin 8
• Lipocalin 2
• Macrophage Inflammatory Protein 1 alpha
• Macrophage Inflammatory Protein 1 delta
• Macrophage inflammatory protein 1 beta
• Plasminogen activator inhibitor-1
• Resistin
• Serum Amyloid A
• Serum Amyloid P
• Soluble Interleukin 4 Receptor
• Soluble Interleukin 6 Receptor
• Soluble Interleukin 6 beta
• Stem Cell Factor
• Thrombopoietin
• Thymic Stromal Lymphopoietin
• Thymus and Activation Regulated Chemokine
• Transforming Growth Factor Alpha
• Tumor Necrosis Factor Alpha
• Tumor Necrosis Factor Beta
• Tumor Necrosis Factor Receptor 1
• Tumor Necrosis Factor Receptor 2
• Tumor Necrosis Factor Receptor Superfamily, Member 10
• Vascular Endothelial Growth Factor
• Vascular endothelial growth factor receptor 2
• Vascular endothelial growth factor receptor 3

Number of Cases: 63

Number of Controls: 63

---